Literature DB >> 11820297

Evaluation of the predictive power of calculation procedure for molecular hydrophobicity of some estradiol derivates.

Tatjana Djaković-Sekulić1, Marijana Acanski, Nada Persić-Janjić.   

Abstract

Several calculation procedures for log P values based on the fragmental and atomic contributions are compared with experimental reversed-phase liquid chromatography (RPLC) retention of estradiol derivates. The RPLC experiments were performed on HPTLC and HPLC commercially available stationary phases. Binary solvent mixtures of methanol-water and acetonitrile-water were used as mobile phases. The correlation between log P and various chromatographically obtained hydrophobicity parameters (R(M)0, log k(w) and phi0) are quantified. The R(M)0, i.e., log k(w) were obtained by linear extrapolation of retention to 0% organic modifier. Phi0 values were obtained from the slopes and intercepts of such linear relationship. The mutual relationship between phi(0,MeOH) and phi(0,ACN) values of the compounds were discussed. The obtained statistical results can be summarized in the following order of reliabilities for different log P calculation methods: Broto>ACD/logP>Crippen>Rekker>Viswanadhan.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11820297     DOI: 10.1016/s0378-4347(01)00435-2

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy.

Authors:  S Hariharan; V Bhardwaj; I Bala; J Sitterberg; U Bakowsky; M N V Ravi Kumar
Journal:  Pharm Res       Date:  2006-11-08       Impact factor: 4.200

2.  Lipophilicity Examination of Some ACE inhibitors andHydrochlorothiazide on Cellulose in RP Thin-Layer Chromatography.

Authors:  Jadranka Odović; Katarina Karljiković-Rajić; Jasna Trbojević-Stanković; Biljana Stojimirović; Sote Vladimirov
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.